Tag: Health Care

Grail (GRAL) stock plunged around 50% in after-hours trading Thursday after the biotech company’s cancer trial results disappointed investors.

On Tuesday, Labcorp Holdings Inc. (LH) reported fourth-quarter adjusted earnings that exceeded analyst expectations, while revenue came in slightly below estimates as the diagnostic testing giant wrapped up its fiscal year 2025.

CVS Health on Tuesday reported fourth-quarter earnings and revenue that beat estimates and reaffirmed the 2026 profit guidance that impressed investors, signaling steady progress in the health-care giant’s turnaround plan.

Shares of several big-name health care companies plunged after the Trump administration proposed nearly flat rates for Medicare Advantage insurers.

Την αλλαγή του μοντέλου λειτουργίας της αγοράς υγείας όπου οι ασφαλιστικές εταιρείες περιορίζονται να λειτουργούν ως παθητικοί μεσάζοντες στις σχέσεις τους με τα νοσοκομεία, επιδιώκει η κίνηση της Τράπεζας Πειραιώς για την εξαγορά της Βιοϊατρικής.

On Thursday, Neogen Corporation (NEOG) reported second-quarter earnings that significantly exceeded analyst expectations, despite a slight year-over-year revenue decline.

Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, gaining access to an experimental drug for flu prevention in its effort to diversify ahead of patent loss for its blockbuster cancer drug Keytruda.

U.S. President Donald Trump on Thursday unveiled sweeping new import tariffs, including 100% duties on branded drugs and 25% levies on heavy-duty trucks, set to come into force next week.

Centene stock was tumbling on Friday after ballooning medical costs led to the health insurer reporting a surprise quarterly loss.

Centene Corp. stock was plunging in premarket trading on Wednesday after the health insurance marketplace provider pulled its 2025 guidance, the latest bit of bad news for a sector that’s been battered by ballooning medical costs.

Shares of Solventum are trading. The initial price is $80.

Oct 10 (Reuters) – Novo Nordisk (NOVOb.CO) said on Tuesday it will stop a trial studying Ozempic to treat kidney failure in diabetes patients ahead of schedule because it was clear from an interim analysis that the treatment would succeed.

Το ενδεχόμενο να δοκιμάσει την πώληση του εν Ελλάδι (μαζί με Κύπρο;) ομίλου κλινικών και διαγνωστικών κέντρων που έχει δημιουργήσει εξετάζει, σύμφωνα με πληροφορίες από τον χρηματοπιστωτικό κλάδο, η CVC Capital Partners.

Novavax on Tuesday posted an unexpected second-quarter profit on earlier-than-expected revenue from its COVID-19 vaccine, but still trimmed its full-year forecast for sales of the shot.

CVS Health CVS –0.99% on Wednesday reported second-quarter earnings that beat analysts’ expectations.

Pfizer on Tuesday reported second-quarter adjusted earnings that topped Wall Street’s expectations, but posted revenue that came under estimates due to a steep drop in Covid product sales.

CVS Health Corp. will slash about 5,000 jobs in a cost-cutting move, the Wall Street Journal reported Monday night. According to the report, the layoffs are primarily in corporate positions, and the company doesn’t expect customer-facing positions in its stores, clinics and pharmacies to be affected.

One of the world’s most common artificial sweeteners is set to be declared a possible carcinogen next month by a leading global health body, according to two sources with knowledge of the process, pitting it against the food industry and regulators.

Shares of UnitedHealth Group and other insurance providers tumbled Wednesday after the company said that seniors have been catching up on procedures delayed during the pandemic, leading to rising costs for insurers.

Novavax said Tuesday that it would cut around a quarter of its workforce as it reported a steeper fall in revenue than expected for the first quarter of the year. Shares surged as investors bet the move could save enough money to to allow the Covid-19 vaccine manufacturer to bring new shots to the market.